Dermatology Drugs Global Market Report 2018

Dermatology Drugs Global Market Report 2018
Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018

SKU CODE : 3251 | Format :

The dermatology drugs market includes medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hair loss, acne, immune disorders (including psoriasis), microbial infections (bacterial, fungal, and viral), vascular and pigmented lesion removal, common warts, seborrheic keratosis, and other skin diseases The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing. Dermatology drugs used to treat acne include local anesthetics, cleansers, anti-inflammatory agents, anti-infectives, emollients, and astringents. These drugs are available for both topical (external) use and internal use. These drugs can be sold as over-the-counter (OTC) as well as prescription drugs. Major OTC dermatological drugs include Differin, Lamisil, Monistat, and Abreva. Some of the major dermatology prescription drugs include Clobetasol propionate, Flucinonide, Baxdela, Siliq, Rhofade.

North America was the largest region in the dermatology drugs market in 2017, accounting for 31% market share. This can be attributed to large number of affluent patients and generous reimbursement within the US pharma market. Asia Pacific was the second largest region accounting for 29% market share. Africa was the smallest region accounting for 3% market share.

Pharmaceutical companies are offering new drugs referred to as immune modulators for the treatment of skin diseases such as eczema. Eczema is a chronic skin condition caused by the lack of skin proteins that results in inflammation and irritation in the skin. These drugs are used to externally treat the skin without changing the immune system of the body. In addition, unlike topical steroids, these new medications do not cause thinning of the skin and breaking of superficial blood vessels. Tacrolimus (Protopic) and Pimecrolimus (Elidel) are major drugs available for the treatment of eczema.

Pharmaceutical Drugs Global Market Report 2018

Pharmaceutical Drugs Global Market Report 2018

Contract Research Organizations Global Market Report 2018

Pharmaceutical Drugs Global Market Report 2018

Contract Research Organizations Global Market Report 2018

Biologics Global Market Report 2018

Minor Orthopedic Replacement Implants Global Market Report 2018

Minor Orthopedic Replacement Implants Global Market Report 2018

Organ-On-Chip Global Market 2018

View Report

Organ-On-Chip Global Market 2018

View Report

Organ-On-Chip Global Market 2018

View Report

Organ-On-Chip Global Market 2018

View Report

Organ-On-Chip Global Market 2018

View Report

Bio-Pharmaceutical Logistics Global Market Report 2018

View Report

Bio-Pharmaceutical Logistics Global Market Report 2018

View Report

Bio-Pharmaceutical Logistics Global Market Report 2018

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)